Right now the price per share is 3,02$, Revance The is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Abhay Joshi (COO & President-Research & Development), Azita Nejad (Senior Vice President-Technical Operations), Conor Gallagher (Head-Medical Affairs & Aesthetics), Mark J. Foley (President, Chief Executive Officer & Director), Roman G. Rubio (Senior Vice President-Clinical Development), Tobin C. Schilke (Chief Financial Officer) and its address is 1222 DEMONBREUN STREET SUITE 1001, NASHVILLE, Tennessee, 37203, United States.
Today this action begins with yesterday's closing price, desconocido$.
With an intraday difference of 3,11$ moving between 3,02$ and 3,21$, it is a notable difference that allows quick purchases and sales.
The company has an annual revenue of desconocido.
The last value we have registered for the opening is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
